Not all postmenopausal women on chronic steroid and estrogen treatment are osteoporotic: Predictors of bone mineral density

J. M. Thompson, G. W. Modin, C. D. Arnaud, Nancy E Lane

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Chronic steroid use results in osteoporosis, and postmenopausal women are believed to be at high risk for steroid-induced bone loss. The purpose of this study was to determine predictors of bone mineral density (BMD) in postmenopausal women on both chronic steroid and hormone replacement therapy. Seventy-six postmenopausal women (≤3 years postmenopausal, ≤2 years of steroid treatment of ≤5 mg/day of prednisolone, and ≤1 year of hormone replacement therapy) were recruited into this study. Measurements of BMD of the lumbar spine and femoral neck were obtained in all subjects. Risk factors for osteoporosis were obtained by questionnaire. Discriminant analysis was performed to determine predictors of BMD. Osteoporosis, defined by a T score of <-2.5, was present in the lumbar spine or femoral neck in 34 of the 76 subjects. Based on these criteria, women with osteoporosis were significantly older, were more years postmenopausal, and had a lower body mass index (BMI) than women who did not have osteoporosis. Predictors of osteoporosis for both the femoral neck and spine included a low BMI (P <0.05), more years postmenopausal (P < 0.01), and more years on steroids (P < 0.01). Low BMI was the only significant predictor of osteoporosis in the lumbar spine (P < 0.05), whereas for the femoral neck both years on steroids (P < 0.05) and BMI (P < 0.05) were significant predictors of low BMD. In summary, not all postmenopausal women on chronic steroid and hormone replacement therapy are osteoporotic but a low BMI, more years on steroids, and more years postmenopausal were significant predictors of osteoporosis in these subjects.

Original languageEnglish (US)
Pages (from-to)377-381
Number of pages5
JournalCalcified Tissue International
Volume61
Issue number5
DOIs
StatePublished - Nov 1997
Externally publishedYes

Fingerprint

Bone Density
Estrogens
Osteoporosis
Steroids
Femur Neck
Body Mass Index
Hormone Replacement Therapy
Spine
Therapeutics
Postmenopausal Osteoporosis
Discriminant Analysis
Prednisolone
Bone and Bones

Keywords

  • Chronic
  • Estrogen
  • Osteoporosis
  • Postmenopausal women
  • Predictors
  • Steroid

ASJC Scopus subject areas

  • Endocrinology

Cite this

Not all postmenopausal women on chronic steroid and estrogen treatment are osteoporotic : Predictors of bone mineral density. / Thompson, J. M.; Modin, G. W.; Arnaud, C. D.; Lane, Nancy E.

In: Calcified Tissue International, Vol. 61, No. 5, 11.1997, p. 377-381.

Research output: Contribution to journalArticle

@article{7d6c7603eb4442a3aeb91d7b63322416,
title = "Not all postmenopausal women on chronic steroid and estrogen treatment are osteoporotic: Predictors of bone mineral density",
abstract = "Chronic steroid use results in osteoporosis, and postmenopausal women are believed to be at high risk for steroid-induced bone loss. The purpose of this study was to determine predictors of bone mineral density (BMD) in postmenopausal women on both chronic steroid and hormone replacement therapy. Seventy-six postmenopausal women (≤3 years postmenopausal, ≤2 years of steroid treatment of ≤5 mg/day of prednisolone, and ≤1 year of hormone replacement therapy) were recruited into this study. Measurements of BMD of the lumbar spine and femoral neck were obtained in all subjects. Risk factors for osteoporosis were obtained by questionnaire. Discriminant analysis was performed to determine predictors of BMD. Osteoporosis, defined by a T score of <-2.5, was present in the lumbar spine or femoral neck in 34 of the 76 subjects. Based on these criteria, women with osteoporosis were significantly older, were more years postmenopausal, and had a lower body mass index (BMI) than women who did not have osteoporosis. Predictors of osteoporosis for both the femoral neck and spine included a low BMI (P <0.05), more years postmenopausal (P < 0.01), and more years on steroids (P < 0.01). Low BMI was the only significant predictor of osteoporosis in the lumbar spine (P < 0.05), whereas for the femoral neck both years on steroids (P < 0.05) and BMI (P < 0.05) were significant predictors of low BMD. In summary, not all postmenopausal women on chronic steroid and hormone replacement therapy are osteoporotic but a low BMI, more years on steroids, and more years postmenopausal were significant predictors of osteoporosis in these subjects.",
keywords = "Chronic, Estrogen, Osteoporosis, Postmenopausal women, Predictors, Steroid",
author = "Thompson, {J. M.} and Modin, {G. W.} and Arnaud, {C. D.} and Lane, {Nancy E}",
year = "1997",
month = "11",
doi = "10.1007/s002239900351",
language = "English (US)",
volume = "61",
pages = "377--381",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Not all postmenopausal women on chronic steroid and estrogen treatment are osteoporotic

T2 - Predictors of bone mineral density

AU - Thompson, J. M.

AU - Modin, G. W.

AU - Arnaud, C. D.

AU - Lane, Nancy E

PY - 1997/11

Y1 - 1997/11

N2 - Chronic steroid use results in osteoporosis, and postmenopausal women are believed to be at high risk for steroid-induced bone loss. The purpose of this study was to determine predictors of bone mineral density (BMD) in postmenopausal women on both chronic steroid and hormone replacement therapy. Seventy-six postmenopausal women (≤3 years postmenopausal, ≤2 years of steroid treatment of ≤5 mg/day of prednisolone, and ≤1 year of hormone replacement therapy) were recruited into this study. Measurements of BMD of the lumbar spine and femoral neck were obtained in all subjects. Risk factors for osteoporosis were obtained by questionnaire. Discriminant analysis was performed to determine predictors of BMD. Osteoporosis, defined by a T score of <-2.5, was present in the lumbar spine or femoral neck in 34 of the 76 subjects. Based on these criteria, women with osteoporosis were significantly older, were more years postmenopausal, and had a lower body mass index (BMI) than women who did not have osteoporosis. Predictors of osteoporosis for both the femoral neck and spine included a low BMI (P <0.05), more years postmenopausal (P < 0.01), and more years on steroids (P < 0.01). Low BMI was the only significant predictor of osteoporosis in the lumbar spine (P < 0.05), whereas for the femoral neck both years on steroids (P < 0.05) and BMI (P < 0.05) were significant predictors of low BMD. In summary, not all postmenopausal women on chronic steroid and hormone replacement therapy are osteoporotic but a low BMI, more years on steroids, and more years postmenopausal were significant predictors of osteoporosis in these subjects.

AB - Chronic steroid use results in osteoporosis, and postmenopausal women are believed to be at high risk for steroid-induced bone loss. The purpose of this study was to determine predictors of bone mineral density (BMD) in postmenopausal women on both chronic steroid and hormone replacement therapy. Seventy-six postmenopausal women (≤3 years postmenopausal, ≤2 years of steroid treatment of ≤5 mg/day of prednisolone, and ≤1 year of hormone replacement therapy) were recruited into this study. Measurements of BMD of the lumbar spine and femoral neck were obtained in all subjects. Risk factors for osteoporosis were obtained by questionnaire. Discriminant analysis was performed to determine predictors of BMD. Osteoporosis, defined by a T score of <-2.5, was present in the lumbar spine or femoral neck in 34 of the 76 subjects. Based on these criteria, women with osteoporosis were significantly older, were more years postmenopausal, and had a lower body mass index (BMI) than women who did not have osteoporosis. Predictors of osteoporosis for both the femoral neck and spine included a low BMI (P <0.05), more years postmenopausal (P < 0.01), and more years on steroids (P < 0.01). Low BMI was the only significant predictor of osteoporosis in the lumbar spine (P < 0.05), whereas for the femoral neck both years on steroids (P < 0.05) and BMI (P < 0.05) were significant predictors of low BMD. In summary, not all postmenopausal women on chronic steroid and hormone replacement therapy are osteoporotic but a low BMI, more years on steroids, and more years postmenopausal were significant predictors of osteoporosis in these subjects.

KW - Chronic

KW - Estrogen

KW - Osteoporosis

KW - Postmenopausal women

KW - Predictors

KW - Steroid

UR - http://www.scopus.com/inward/record.url?scp=0030694518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030694518&partnerID=8YFLogxK

U2 - 10.1007/s002239900351

DO - 10.1007/s002239900351

M3 - Article

C2 - 9351878

AN - SCOPUS:0030694518

VL - 61

SP - 377

EP - 381

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 5

ER -